A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
NCT07213791
This study is recruiting at 16 US sites in 12 states, according to its ClinicalTrials.gov record last updated .
Summary
This is a study of LY4337713 in participants with certain types of cancer that is advanced or has spread. Participants must have cancer with high levels of a protein called fibroblast activation protein (FAP). The purpose of this study is to evaluate safety, side effects, and efficacy of LY4337713. In addition, this study will evaluate how much LY4337713 gets into the bloodstream, how it is broken down, and how long it takes the body to get rid of it. For each participant, the study will last about 5 years.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Ovarian Neoplasms
- Breast Neoplasms
- Pancreatic Intraductal Neoplasms
- Colorectal Neoplasms
- Esophageal Neoplasms
- Stomach Neoplasms
- Cholangiocarcinoma
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Eli Lilly and Company
- Last updated on ClinicalTrials.gov
- September 22, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 2
- Hoag Memorial Hospital Presbyterian · Newport Beach, CA
- Stanford University Medical Center · Stanford, CA
Florida · 1
- Moffitt · Tampa, FL
Indiana · 1
- Indiana University (IU) School of Medicine · Indianapolis, IN
Maryland · 1
- United Theranostics · Glen Burnie, MD
Massachusetts · 1
- Massachusetts General Hospital · Boston, MA
Michigan · 2
- Barbara Ann Karmanos Cancer Institute · Detroit, MI
- BAMF Health Inc. · Grand Rapids, MI
Missouri · 1
- Washington University School of Medicine in St. Louis · St Louis, MO
New York · 2
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center · New York, NY
- New York University (NYU) Clinical Cancer Center · New York, NY
North Carolina · 1
- Duke University Medical Center · Durham, NC
Pennsylvania · 2
- Fox Chase Cancer Center · Philadelphia, PA
- University of Pennsylvania · Philadelphia, PA
Texas · 1
- Texas Oncology - DFW (Sammons CC) · Dallas, TX
Wisconsin · 1
- University of Wisconsin - Carbone Cancer Center · Madison, WI
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.